Can you provide the average price target for XPENG INC - ADR stock?
34 analysts have analysed XPEV and the average price target is 24.26 USD. This implies a price increase of 37.05% is expected in the next year compared to the current price of 17.7.
XPENG INC - ADR (XPEV) Forecast, Price Target & Analyst Ratings
NYSE:XPEV • US98422D1054
Current stock price
17.7 USD
+0.19 (+1.09%)
At close:
17.75 USD
+0.05 (+0.28%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XPENG INC - ADR (XPEV).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 21, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -CN¥1.00
- Revenue Estimate
- 13.291B
Price Target Details & History
Consensus Price Target and Range
Mean target
$24.26
Upside
+ 37.05%
From current price of $17.70 to mean target of $24.26, Based on 34 analyst forecasts
Low
$16.16
Median
$23.46
High
$35.70
Price Target Revisions
1 Month
-6.49%
3 Months
-12.81%
Price Target Summary
34 Wall Street analysts provided a forecast for the next 12 months for XPEV. The average price target is 24.26 USD. This implies a price increase of 37.05% is expected in the next year compared to the current price of 17.7.
The average price target has been revised downward by 12.81% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
79.41%
XPEV was analyzed by 34 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about XPEV.
In the previous month the buy percentage consensus was at a similar level.
XPEV was analyzed by 34 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-24 | Barclays | Maintains | Underweight -> Underweight |
| 2026-03-23 | Macquarie | Downgrade | Outperform -> Neutral |
| 2026-01-06 | Freedom Capital Markets | Upgrade | Hold -> Buy |
| 2025-08-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-15 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-05-22 | Macquarie | Upgrade | Neutral -> Outperform |
| 2025-03-20 | Barclays | Maintains | Underweight -> Underweight |
| 2025-03-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-10 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-02-24 | UBS | Upgrade | Sell -> Neutral |
| 2025-02-07 | Macquarie | Downgrade | Outperform -> Neutral |
| 2024-12-05 | UBS | Downgrade | Neutral -> Sell |
| 2024-11-22 | China Renaissance | Upgrade | Hold -> Buy |
| 2024-11-20 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2024-11-20 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-09-05 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-08-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-21 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-07-16 | B of A Securities | Maintains | Buy -> Buy |
| 2024-06-25 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-04-15 | Macquarie | Reiterate | Neutral |
| 2024-03-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 21, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -CN¥1.00
- Revenue Estimate
- 13.291B
- Revenue Q2Q
- -15.94%
- EPS Q2Q
- -42.65%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
-25.02%
Revenue (3 Months)
-39.43%
EPS (1 Month)
-190.72%
EPS (3 Months)
-563.73%
Next Earnings Summary
XPEV is expected to report earnings on 5/21/2026. The consensus EPS estimate for the next earnings is -1 USD and the consensus revenue estimate is 13.29B USD.
The next earnings revenue estimate has been revised downward by 39.43% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30.676B 14.23% | 40.866B 33.22% | 76.72B 87.73% | 96.799B 26.17% | 123.36B 27.44% | 135.587B 9.91% | 158.585B 16.96% | 176.673B 11.41% | 194.223B 9.93% | 215.576B 10.99% | 233.106B 8.13% | |
| EBITDA YoY % growth | -7.906B -4.46% | -3.702B 53.18% | N/A 73.98% | 3.07B 418.71% | 5.466B 78.05% | 11.108B 103.22% | 12.519B 12.70% | 14.096B 12.60% | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.782B -14.42% | -5.811B 40.60% | -2.654B 54.33% | -273.605M 89.69% | 2.64B 1,064.90% | 7.993B 202.77% | 11.76B 47.13% | 14.313B 21.71% | 16.652B 16.34% | 19.26B 15.66% | 21.246B 10.31% | |
| Operating Margin | -31.89% | -14.22% | -3.46% | -0.28% | 2.14% | 5.90% | 7.42% | 8.10% | 8.57% | 8.93% | 9.11% | |
| EPS YoY % growth | -11.96 -14.01% | -6.11 48.91% | -1.20 80.36% | 0.70 158.21% | 3.46 394.97% | 4.06 17.29% | 5.18 27.85% | 5.92 14.26% | N/A | N/A | N/A |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.00 -42.65% | -0.67 -33.55% | 0.15 138.68% | 0.74 85.05% | 0.40 140.14% | 0.48 172.10% | 0.31 97.80% | 0.56 -24.76% | 0.24 -40.71% | 0.36 -24.79% | 0.45 46.33% | 0.61 8.79% |
| Revenue Q2Q % growth | 13.291B -15.94% | 21.875B 19.70% | 28.424B 39.46% | 33.624B 51.09% | 27.981B 110.53% | 30.842B 40.99% | 33.991B 19.59% | 38.352B 14.06% | 31.491B 12.54% | 34.79B 12.80% | 38.552B 13.42% | 43.862B 14.37% |
| EBITDA Q2Q % growth | -613.395M 67.21% | -567.683M -201.81% | -69.65M 86.80% | 186.21M 141.22% | 348.36M 156.79% | 537.06M 194.61% | 114.26M 264.05% | 610.92M 228.08% | -68.787M -119.75% | 73.731M -86.27% | 248.73M 117.69% | 528.98M -13.41% |
| EBIT Q2Q % growth | -1.331B -44.21% | -799.188M -33.50% | 60.796M 108.98% | 651.31M 866.23% | 348.36M 126.17% | 537.06M 167.20% | 114.26M 87.94% | 610.92M -6.20% | -68.787M -119.75% | 73.731M -86.27% | 248.73M 117.69% | 528.98M -13.41% |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
75.22%
EPS Next 5 Year
47.31%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
19.98%
Revenue Next 5 Year
17.61%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
77.93%
EBIT Next 5 Year
45.90%
XPENG INC - ADR / XPEV Forecast FAQ
What is the next earnings date for XPEV stock?
XPENG INC - ADR (XPEV) will report earnings on 2026-05-21.
Can you provide the consensus estimates for XPENG INC - ADR next earnings?
The consensus EPS estimate for the next earnings of XPENG INC - ADR (XPEV) is -1 USD and the consensus revenue estimate is 13.29B USD.
How do analysts rate XPENG INC - ADR (XPEV)?
The consensus rating for XPENG INC - ADR (XPEV) is 79.4118 / 100 . This indicates that analysts generally have a positive outlook on the stock.